Filter
1023
Text search:
pharmaceutical
performance
Featured
Recommendations
94
New Publications
318
Language
Document type
No document type
595
Studies & Reports
162
Guidelines
141
Strategic & Response Plan
50
Manuals
44
Training Material
14
Situation Updates
8
Fact sheets
7
Resource Platforms
2
Countries / Regions
Ethiopia
52
Kenya
47
India
44
Uganda
32
Global
30
South Africa
29
Nigeria
28
Liberia
25
Sierra Leone
23
Ghana
21
Tanzania
21
Zambia
20
Rwanda
19
Western and Central Europe
18
Namibia
16
Nepal
15
Malawi
15
Africa
13
Zimbabwe
11
Philippines
11
Indonesia
11
Bangladesh
11
Ukraine
11
Eastern Europe
10
Syria
9
Lesotho
9
Cambodia
8
Myanmar / Burma
8
Botswana
7
West and Central Africa
7
Eswatini/ Swaziland
6
Latin America and the Carribbean
6
Congo, Democratic Republic of
5
Cameroon
5
Benin
5
East and Southern Africa
5
Senegal
4
Thailand
4
South–East Asia Region
4
Asia
4
Burkina Faso
3
Germany
3
Western Pacific Region
3
Albania
3
South Sudan
2
Iraq
2
Jordan
2
Egypt
2
China
2
Brazil
2
Middle East and North Africa
2
Jamaica
2
Guinea
1
Mali
1
Saudi Arabia
1
Niger
1
Pakistan
1
Afghanistan
1
Lebanon
1
Chad
1
Ireland
1
Mozambique
1
Papua New Guinea
1
Sudan
1
North Macedonia
1
Eastern Europe and Central Asia
1
Fiji
1
Southern Africa
1
Laos
1
Timor Leste/ East Timor
1
Tajikistan
1
Bulgaria
1
Lithuania
1
Moldova
1
Iran
1
Kyrgyzstan
1
Australia
1
Vietnam
1
North America
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
495
Clinical Guidelines
61
Public Health
47
Key Resources
39
Pharmacy & Technologies
27
Women & Child Health
19
Capacity Building
10
Toolboxes
Pharmacy
92
AMR
73
COVID-19
67
TB
61
Mental Health
44
HIV
42
Rapid Response
26
Planetary Health
21
Caregiver
19
NTDs
19
NCDs
19
Global Health Education
16
Conflict
15
Health Financing Toolbox
14
Polio
6
Disability
5
Refugee
5
Specific Hazards
5
Ebola
4
Natural Hazards
4
Cholera
2
Health Financing
2
Zika
1
Replacement of Annex 2 of WHO Technical Report Series, No. 964
...
The main objectives of these guidelines are to:
1. contribute to the quality assurance of medicinal plant materials used as the source for herbal medicines to improve the quality, safety and efficacy of finished herbal products; 2. guide the formulation of national and/or regional GACP guideli ...
1. contribute to the quality assurance of medicinal plant materials used as the source for herbal medicines to improve the quality, safety and efficacy of finished herbal products; 2. guide the formulation of national and/or regional GACP guideli ...
This report has been developed, based on data provided by the TB & ORD surveillance system from across Rwanda. It provides a comprehensive picture of the occurrence and management of TB & ORD and Leprosy in Rwanda. It is structured based on the 2013-2018 Rwanda TB national strategic plan (2013-2018
...
For the Fiscal Year 2014-2015, the Health Sector continued to implement interventions and strategies meant to improve the availability, accessibility and utilization of quality healthcare services across public and private health facilities; and to ensure the reduction of the burden of communicable
...
This CPD Policy relates to all health professionals in the four Health Professional Councils in Rwanda namely; RMDC, NCNM, RAHPC, and RPC. The policy requires all health professionals to participate in the CPD Programs. The purpose of this CPD Policy is to support the professionals in the respective
...
Rwanda’s fourth health sector strategic plan (HSSP4) is meant to provide the health sector with a Strategic Plan that will highlight its commitments and priorities for the coming 6 years. It will be fully integrated in the overall economic development plan of the Government. HSSP4 will fulfill the
...
This report is primarily intended for the community of policymakers and researchers concerned about the rising risks of domestic, regional, and global infectious disease epidemics, and the collective failure to take the coordinated actions required to reduce such risks. These risks include the expec
...
Conducted November 2011 to February 2012: Summary Report
This summary report has five sections. Following the introduction (Section 1), Section 2 sets out summary findings and recommendations of the assessment team. Section 3 describes the context in which artemisinin resistance is being tackle ...
This summary report has five sections. Following the introduction (Section 1), Section 2 sets out summary findings and recommendations of the assessment team. Section 3 describes the context in which artemisinin resistance is being tackle ...
Guidelines for drinking-water quality: Fourth edition incorporating the first and second addenda
recommended
Guidance has been updated on a number of chemicals: asbestos, bentazone, chromium, iodine, manganese, microcystins, nickel, silver, tetrachloroethene and trichloroethene. Guidance has also been added for chemicals not previously assessed in the Guidelines: anatoxin-a and analogues, cylindrospermopsi
...
(Health Systems in Transition, Vol. 4, No. 3, 2014)
The vision of the new Strategic Action Plan for Strengthening HIS in Myanmar 2017- 2021 is “A strong health information system for a strong health system”. The mission statement of HIS in Myanmar also developed during the strategic planning exercise is “Generating and making accessible compreh
...
The health of the people and health services are in crisis, and together as partners this plan commits us to strategies aimed at achieving our goal of:
Strengthened primary health care for all, and improved service delivery for the rural majority and the urban disadvantaged.
Original fi ...
Strengthened primary health care for all, and improved service delivery for the rural majority and the urban disadvantaged.
Original fi ...
It provides insight into WHO’s work that aims to improve the health of the people of the United Republic of Tanzania in collaboration with key stakeholders.
The purpose of the landscape analysis is ultimately to facilitate improved engagement of private providers, thereby contributing to universal access to quality and affordable TB care and the end of the TB epidemic. It focuses on the role of private for-profit providers and on specific challenges and
...
Accessed January 22, 2019.
This updated version include important research that has added to our knowledge about effective treatments for
child and adolescent depression. Its goal is to help parents and families make informed decisions about getting the best care for a child with depression. For
...
Global Happiness Council
This guide was developed by AACAP to give reliable information about medication
used to treat bipolar disorder in children and adolescents to parents whose children
have been diagnosed with the illness.
Sci Rep. 2016; 6: 25920. Published online 2016 May 16. doi: 10.1038/srep25920
